Free Trial

GeoVax Labs (GOVX) Competitors

GeoVax Labs logo
$1.72 -0.03 (-1.75%)
As of 01:35 PM Eastern

GOVX vs. HOWL, OPTN, VTVT, IMRX, KRON, ACHL, UNCY, ALXO, PRLD, and IMMX

Should you be buying GeoVax Labs stock or one of its competitors? The main competitors of GeoVax Labs include Werewolf Therapeutics (HOWL), OptiNose (OPTN), vTv Therapeutics (VTVT), Immuneering (IMRX), Kronos Bio (KRON), Achilles Therapeutics (ACHL), Unicycive Therapeutics (UNCY), ALX Oncology (ALXO), Prelude Therapeutics (PRLD), and Immix Biopharma (IMMX). These companies are all part of the "pharmaceutical products" industry.

GeoVax Labs vs.

GeoVax Labs (NASDAQ:GOVX) and Werewolf Therapeutics (NASDAQ:HOWL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk, community ranking and profitability.

GeoVax Labs has a beta of 3.28, suggesting that its stock price is 228% more volatile than the S&P 500. Comparatively, Werewolf Therapeutics has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500.

In the previous week, GeoVax Labs had 1 more articles in the media than Werewolf Therapeutics. MarketBeat recorded 1 mentions for GeoVax Labs and 0 mentions for Werewolf Therapeutics. GeoVax Labs' average media sentiment score of 0.00 equaled Werewolf Therapeutics'average media sentiment score.

Company Overall Sentiment
GeoVax Labs Neutral
Werewolf Therapeutics Neutral

Werewolf Therapeutics received 8 more outperform votes than GeoVax Labs when rated by MarketBeat users. However, 96.00% of users gave GeoVax Labs an outperform vote while only 69.57% of users gave Werewolf Therapeutics an outperform vote.

CompanyUnderperformOutperform
GeoVax LabsOutperform Votes
24
96.00%
Underperform Votes
1
4.00%
Werewolf TherapeuticsOutperform Votes
32
69.57%
Underperform Votes
14
30.43%

6.1% of GeoVax Labs shares are held by institutional investors. Comparatively, 64.8% of Werewolf Therapeutics shares are held by institutional investors. 5.7% of GeoVax Labs shares are held by insiders. Comparatively, 21.1% of Werewolf Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

GeoVax Labs has a net margin of 0.00% compared to Werewolf Therapeutics' net margin of -578.80%. Werewolf Therapeutics' return on equity of -58.83% beat GeoVax Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
GeoVax LabsN/A -809.87% -349.34%
Werewolf Therapeutics -578.80%-58.83%-38.45%

GeoVax Labs has higher earnings, but lower revenue than Werewolf Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeoVax Labs$80K204.01-$25.97MN/AN/A
Werewolf Therapeutics$19.94M3.18-$37.37M-$1.53-0.93

GeoVax Labs presently has a consensus target price of $14.20, suggesting a potential upside of 721.33%. Werewolf Therapeutics has a consensus target price of $9.33, suggesting a potential upside of 554.97%. Given GeoVax Labs' stronger consensus rating and higher probable upside, research analysts plainly believe GeoVax Labs is more favorable than Werewolf Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GeoVax Labs
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.29
Werewolf Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

GeoVax Labs beats Werewolf Therapeutics on 10 of the 16 factors compared between the two stocks.

Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GOVX vs. The Competition

MetricGeoVax LabsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$16.32M$6.99B$5.82B$9.21B
Dividend YieldN/A2.90%5.23%3.99%
P/E RatioN/A6.1025.0919.35
Price / Sales204.01322.94466.4479.81
Price / CashN/A72.6944.6537.93
Price / Book0.536.477.605.21
Net Income-$25.97M$138.54M$3.19B$246.05M
7 Day Performance-0.06%1.63%1.43%1.92%
1 Month Performance-22.12%1.39%3.51%1.43%
1 Year Performance-26.43%0.04%20.04%16.14%

GeoVax Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GOVX
GeoVax Labs
2.5088 of 5 stars
$1.72
-1.7%
$14.20
+725.9%
-25.5%$16.23M$80,000.000.0010News Coverage
HOWL
Werewolf Therapeutics
2.328 of 5 stars
$1.30
-4.6%
$9.33
+619.1%
-79.0%$58.15M$19.94M-0.8540
OPTN
OptiNose
4.1159 of 5 stars
$5.71
-1.7%
$16.67
+191.9%
-71.4%$57.44M$75.67M-1.36190Gap Up
VTVT
vTv Therapeutics
1.4782 of 5 stars
$17.91
+0.2%
$35.00
+95.4%
+110.3%$57.43M$2.02M-3.979
IMRX
Immuneering
3.365 of 5 stars
$1.85
-2.9%
$12.20
+561.2%
-72.1%$57.29M$320,000.00-0.9460
KRON
Kronos Bio
3.6794 of 5 stars
$0.95
-2.6%
$1.63
+72.0%
+0.5%$57.02M$6.29M-0.66100
ACHL
Achilles Therapeutics
3.5111 of 5 stars
$1.39
+0.4%
$4.00
+188.8%
+31.1%$56.92MN/A-0.84250
UNCY
Unicycive Therapeutics
3.8003 of 5 stars
$0.54
-4.0%
$5.50
+912.9%
-54.8%$56.36M$680,000.00-0.569Positive News
High Trading Volume
ALXO
ALX Oncology
3.3683 of 5 stars
$1.05
-4.1%
$3.05
+191.9%
-92.5%$56.17MN/A-0.3640
PRLD
Prelude Therapeutics
2.2242 of 5 stars
$1.02
+0.5%
$4.00
+294.1%
-79.5%$55.20MN/A-0.56120Upcoming Earnings
News Coverage
Gap Up
IMMX
Immix Biopharma
2.7192 of 5 stars
$2.00
-0.7%
$7.00
+250.9%
-39.5%$54.86MN/A-2.359Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:GOVX) was last updated on 2/19/2025 by MarketBeat.com Staff
From Our Partners